Medical Technology

@xconomy.com 4 years ago

Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More

@xconomy.com 4 years ago

Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More

@geekwire.com 4 years ago

Fred Hutch spinout SEngine raises $5.1M to test cancer treatment drugs against a patient’s tumors

@xconomy.com 4 years ago

Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More

@xconomy.com 5 years ago

Synthorx Files for IPO to Advance Enhanced Cytokine Drugs

@xconomy.com 5 years ago

OncoNano, Maker of Tumor Imaging Technology, Raises $11.7 Million

@xconomy.com 6 years ago

Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs

@techcrunch.com 7 years ago

Grail is raising at least $1 billion to fund its early cancer screening test